The Trump administration intervened in an internal FDA dispute regarding the regulation of flavored e-cigarettes, siding with tobacco and vaping industry preferences over the agency's own commissioner. Rather than enforcing stricter rules on flavored vapes—which health officials warned were driving youth addiction—the administration allowed a more lenient regulatory path that preserved industry profits. FDA Commissioner Scott Gottlieb, who had championed aggressive action against youth vaping and pushed for stricter flavoring restrictions, resigned in protest over this decision, signaling a fundamental conflict between public health directives and White House priorities.

The direct impact fell on American youth and public health outcomes. Flavored e-cigarettes had become the dominant product among teenage users, with nicotine addiction rates among high school students reaching epidemic levels by 2018-2019. By blocking or delaying comprehensive flavor restrictions, the administration's decision preserved industry access to the youth market, undermining years of FDA work to reverse the youth vaping surge. Tobacco companies, which had contributed significantly to Trump's inaugural committee and related organizations, benefited directly from the regulatory reversal.

This action reflected a broader pattern of Trump administration deference to tobacco and pharmaceutical industry donors at the expense of public health enforcement. It marked a sharp reversal from the Obama-era FDA's aggressive stance on e-cigarette regulation and youth marketing prevention. The move also demonstrated the administration's willingness to override career agency leadership when industry interests conflicted with regulatory missions, a pattern repeated across environmental and consumer protection decisions.

The legal mechanism involved executive branch pressure on the FDA rather than a formal executive order, making it difficult to challenge in court. However, the decision faced criticism from public health organizations and state attorneys general who argued it violated the FDA's statutory mandate under the Family Smoking Prevention and Tobacco Control Act to protect public health. Congressional Democrats called for investigations, though Republican-controlled committees took no action during the first Trump term.

Reversal would require either a new administration prioritizing youth health protection or congressional action to mandate stricter FDA enforcement of flavor restrictions independent of executive discretion. Several states subsequently enacted their own flavor bans, bypassing federal inaction, while the Biden administration later moved to restrict menthol and other flavors through formal rulemaking.